Management of Malnutrition in Oncogeriatrics
Launched by HOSPICES CIVILS DE LYON · May 17, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Management of Malnutrition in Oncogeriatrics" is focused on understanding and treating undernutrition in older cancer patients. Undernutrition is a serious issue, especially among those over 70, and can affect their overall health and recovery. This trial aims to identify patients aged 70 and older who have moderate to severe undernutrition and are currently undergoing cancer treatment. By diagnosing and managing this condition early, the study hopes to improve the health and quality of life for these patients.
If you're a caregiver or family member of an older adult with cancer who might be experiencing undernutrition, this trial could be relevant. Eligible participants must be 70 years or older and diagnosed with moderate to severe undernutrition while receiving cancer treatment. Unfortunately, those under 70, those no longer in active treatment, or those preparing for surgery won't be included. Throughout the study, participants can expect support in managing their nutritional needs, which is vital for their recovery and well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 70 and over with a diagnosis of moderate or severe undernutrition
- • All patients with diagnosed cancer and ongoing cancer treatment.
- Exclusion Criteria:
- • Patients under 70 years of age
- • Hospitalized patients no longer undergoing anticancer treatment
- • All patients undergoing pre-habilitation for surgery
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lyon, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported